This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting central nervous system disorders, such as depression, anxiety, and other psychiatric conditions. Its chiral structure makes it valuable for creating enantiomerically pure compounds, which are often essential for achieving desired therapeutic effects with minimal side effects. Additionally, it may be employed in research settings for studying receptor interactions and developing novel therapeutic agents.